SCLX

Scilex (SCLX)

Scilex Holding Company

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:NASDAQ:SCLX

1 2 3 4 5 6 7 8 9 다음 >>

일자	시간	출처	헤드라인	심볼	기업
2024/09/26	22:00	GlobeNewswire Inc.	Scilex Holding Company Announces that the U.S. Bankruptcy Court has Extended the Lockup Period on Shares of Scilex Dividend Stock Previously Distributed by Sorrento to its Stockholders as a Dividend to January 31, 2025	NASDAQ:SCLX	Scilex Holding Company
2024/09/18	22:00	GlobeNewswire Inc.	Scilex Holding Company Announces the Continuing Support from Endeavor Distribution LLC in the Multi-Year Agreement for Scilex’s Commercial Products and the Satisfaction of FSF 33433 LLC $10 Million Loan	NASDAQ:SCLX	Scilex Holding Company
2024/09/12	22:00	GlobeNewswire Inc.	Scilex Holding Company Announces It Has Received the Drug Distributor Accreditation from the National Association of Boards of Pharmacy® (NABP®)	NASDAQ:SCLX	Scilex Holding Company
2024/09/09	22:00	GlobeNewswire Inc.	Scilex Holding Company to Present at the 26th Annual H.C. Wainwright Global Investment Conference	NASDAQ:SCLX	Scilex Holding Company
2024/09/05	22:00	GlobeNewswire Inc.	Scilex Holding Company Announces Acceptance of Presentation at the 2024 American College of Rheumatology Convergence Conference to be held at the Walter E. Washington Convention Center in Washington, D.C. on November 14 – 19, 2024	NASDAQ:SCLX	Scilex Holding Company
2024/09/03	22:24	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCLX	Scilex Holding Company
2024/09/03	22:14	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCLX	Scilex Holding Company
2024/09/03	22:08	Edgar (US Regulatory)	Form 425 - Prospectuses and communications, business combinations	NASDAQ:SCLX	Scilex Holding Company
2024/09/03	22:06	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SCLX	Scilex Holding Company
2024/09/03	22:00	GlobeNewswire Inc.	Semnur Pharmaceuticals, Inc., a Wholly Owned Subsidiary of Scilex Holding Company, and Denali Capital Acquisition Corp. (Nasdaq: DECA) Announce Signing of a Merger Agreement for a proposed Business Combination	NASDAQ:SCLX	Scilex Holding Company
2024/08/30	22:00	GlobeNewswire Inc.	Scilex Holding Company to Present Oral, Poster Presentations and Symposia on ZTlido (lidocaine topical system) at the 2024 Annual PAINWeek Conference in Las Vegas, NV on September 3-5, 2024	NASDAQ:SCLX	Scilex Holding Company
2024/08/29	22:00	GlobeNewswire Inc.	Scilex Holding Company Announces FDA Final Approval to Precision Dosing for GLOPERBA® Label	NASDAQ:SCLX	Scilex Holding Company
2024/08/21	22:00	GlobeNewswire Inc.	Scilex Holding Company Announces the U.S. Patent and Trademark Office Will Be Issuing New ELYXYB® Patent Related to the Treatment of Acute Pain	NASDAQ:SCLX	Scilex Holding Company
2024/08/20	06:08	Edgar (US Regulatory)	Form 4 - Statement of changes in beneficial ownership of securities	NASDAQ:SCLX	Scilex Holding Company
2024/08/14	05:34	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCLX	Scilex Holding Company
2024/08/14	05:31	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCLX	Scilex Holding Company
2024/08/14	05:10	Edgar (US Regulatory)	Form 10-Q - Quarterly report [Sections 13 or 15(d)]	NASDAQ:SCLX	Scilex Holding Company
2024/08/13	06:07	Edgar (US Regulatory)	Form 3 - Initial statement of beneficial ownership of securities	NASDAQ:SCLX	Scilex Holding Company
2024/08/09	22:00	GlobeNewswire Inc.	Scilex Holding Company Enters into Master Distributor Agreement Among CH Trading Group and Devart Middle East for the Distribution of ZTlido® in Morocco, Tunisia, Libya, Jordan, Iraq, and South Africa	NASDAQ:SCLX	Scilex Holding Company
2024/08/01	22:00	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SCLX	Scilex Holding Company
2024/08/01	22:00	GlobeNewswire Inc.	Scilex Holding Company Provides Certain Preliminary Unaudited Financial Results for the Month Ended July 31, 2024	NASDAQ:SCLX	Scilex Holding Company
2024/07/26	13:15	Edgar (US Regulatory)	Form EFFECT - Notice of Effectiveness	NASDAQ:SCLX	Scilex Holding Company
2024/07/26	10:38	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCLX	Scilex Holding Company
2024/07/26	06:28	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCLX	Scilex Holding Company
2024/07/26	06:28	Edgar (US Regulatory)	Form 424B3 - Prospectus [Rule 424(b)(3)]	NASDAQ:SCLX	Scilex Holding Company
2024/07/26	06:19	Edgar (US Regulatory)	Form 8-K - Current report	NASDAQ:SCLX	Scilex Holding Company
2024/07/24	23:52	GlobeNewswire Inc.	Scilex Holding Company Announces Publication of Its Inaugural Sustainability Report	NASDAQ:SCLX	Scilex Holding Company
2024/07/23	22:00	GlobeNewswire Inc.	Scilex Holding Company Strengthens Board of Directors with Appointment of Highly Accomplished Leader in Interventional and Multidisciplinary Spine, Musculoskeletal and Orthopedic Care, Annu Navani, M.D.	NASDAQ:SCLX	Scilex Holding Company
2024/07/19	05:20	Edgar (US Regulatory)	Form S-3 - Registration statement under Securities Act of 1933	NASDAQ:SCLX	Scilex Holding Company
2024/07/17	22:00	GlobeNewswire Inc.	Scilex Holding Company Announces Collaboration to Leverage ACEA Therapeutics’ R&D Expertise and Local Market Connections to Support the Expansion of ZTlido® Program in ex-US and Potentially Provide Additional Access to Patients in Certain Key Markets in	NASDAQ:SCLX	Scilex Holding Company